Skinvisible, Inc (SKVI.OB) Enters Exclusive License Agreement
Skinvisible, Inc., a pharmaceutical research and development company, announced that the company has entered into an exclusive license agreement with Mayquest Pharmaceuticals Pte. This license agreement grants Skinvisible the exclusive rights for the product Dermsafe in Singapore, Malaysia, Thailand, Indonesia, and the Philippines. Dermsafe is a patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine flu virus. Under the terms of this agreement, Mayquest is to pay an upfront license fee in milestones for the exclusive manufacturing and marketing right. Skinvisible will also receive on-going royalties derived from product sales. Mr. Terry Howlett, President and CEO of Skinvisible,…